M&A

Concentra finds latest acquisition attempt harder to swallow as Atea rejects 'undervalued' offer
Concentra finds latest acquisition attempt harder to swallow as Atea rejects 'undervalued' offer
Fierce Biotech
Concerta Biosciences
M&A
Atea Pharmaceuticals
Flag link:
Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer
Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer
Fierce Pharma
Sun Pharma
M&A
Taro Pharmaceuticals
India
Flag link:
Boston Sci Scraps Majority Stake Deal with M.I. Tech
Boston Sci Scraps Majority Stake Deal with M.I. Tech
Medical Devices and Diagnostics Industry
Medtech
Boston Scientific
M&A
MI Tech
Flag link:
Medtronic Is Sweet on EOFlow
Medtronic Is Sweet on EOFlow
Medical Devices and Diagnostics Industry
Medtronic
diabetes
Medtech
M&A
EOFlow
Flag link:
Purdue Pharma to sell consumer business for $397 mln
Purdue Pharma to sell consumer business for $397 mln
Reuters
Purdue Pharma
M&A
consumer health
Arcardia Consumer Healthcare
Flag link:
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Flag link:
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Astellas
Iveric Bio
Bayer
Amgen
M&A
Flag link:
Concentra rebounds from Jounce buy with a shot at COVID-19-focused Atea
Concentra rebounds from Jounce buy with a shot at COVID-19-focused Atea
Fierce Biotech
Concerta Biosciences
Atea Pharmaceuticals
M&A
COVID-19
Flag link:
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Motley Fool
Pfizer
debt
Seagen
M&A
Flag link:
Ironwood to buy VectivBio for $1.15 billion to boost digestive disorder drugs portfolio
Ironwood to buy VectivBio for $1.15 billion to boost digestive disorder drugs portfolio
Yahoo/Reuters
Ironwood Pharmaceuticals
VectivBio
M&A
digestive disorders
Flag link:
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
CNBC
Horizon Therapeutics
M&A
Amgen
FTC
Flag link:
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Flag link:
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Flag link:
Heightened US antitrust fears rattle biopharma
Heightened US antitrust fears rattle biopharma
EP Vantage
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Flag link:
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
BioSpace
Amgen
Horizon Therapeutics
M&A
FTC
Flag link:
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
Medical Marketing and Media
Amgen
Horizon Therapeutics
FTC
M&A
Flag link:
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
Flag link:
A struggling biotech wraps its main assets into a new drug company
A struggling biotech wraps its main assets into a new drug company
BioPharma Dive
Cyclerion
M&A
Flag link:
Sobi agrees to buy CTI BioPharma for $1.7bn
Sobi agrees to buy CTI BioPharma for $1.7bn
Pharmaceutical Technology
Sobi
CTI BioPharma
M&A
hematology
Flag link:
Biopharma Bets Big on Antibody-Drug Conjugates
Biopharma Bets Big on Antibody-Drug Conjugates
BioSpace
antibody-drug conjugate
Merck
Seagen
M&A
AstraZeneca
BioNTech
Bristol Myers Squibb
Flag link:

Pages